Cargando…
Beta-3-adrenergic Receptor rs4994 Polymorphism Is a Potential Biomarker for the Development of Nonalcoholic Fatty Liver Disease in Overweight/Obese Individuals
Nonalcoholic fatty liver disease (NAFLD) is one of the most prevalent chronic liver diseases. Obesity is the most common and well-established risk factor for NAFLD, but there are large interindividual differences in the relationship between weight status and the development of NAFLD. Beta-3-adrenerg...
Autores principales: | Sakamoto, Yuki, Oniki, Kentaro, Kumagae, Naoki, Morita, Kazunori, Otake, Koji, Ogata, Yasuhiro, Saruwatari, Junji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942826/ https://www.ncbi.nlm.nih.gov/pubmed/31929840 http://dx.doi.org/10.1155/2019/4065327 |
Ejemplares similares
-
Influence of the PNPLA3 rs738409 Polymorphism on Non-Alcoholic Fatty Liver Disease and Renal Function among Normal Weight Subjects
por: Oniki, Kentaro, et al.
Publicado: (2015) -
A Pilot Study Assessing the Possible Combined Effect of Physical Activity and PNPLA3 rs738409 Polymorphism on the Risk for Non-Alcoholic Fatty Liver Disease in the Japanese Elderly General Population
por: Muto, Narumi, et al.
Publicado: (2020) -
Interactive effects of a common γ-glutamyltransferase 1 variant and low high-density lipoprotein-cholesterol on diabetic macro- and micro-angiopathy
por: Jinnouchi, Hideaki, et al.
Publicado: (2015) -
Modeling of the Weight Status and Risk of Nonalcoholic Fatty Liver Disease in Elderly Individuals: The Potential Impact of the Disulfide Bond‐Forming Oxidoreductase A‐Like Protein (DsbA‐L) Polymorphism on the Weight Status
por: Oniki, Kentaro, et al.
Publicado: (2018) -
The longitudinal effect of the aldehyde dehydrogenase 2*2 allele on the risk for nonalcoholic fatty liver disease
por: Oniki, K, et al.
Publicado: (2016)